XML 85 R70.htm IDEA: XBRL DOCUMENT v3.10.0.1

Geographic and Segment Information (Segment Info) (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2018 USD ($) geographic_region	Jun. 30, 2017 USD ($)	Jun. 30, 2018 USD ($) segment geographic_region	Jun. 30, 2017 USD ($)	Jan. 16, 2018	Dec. 31, 2017 USD ($)
Segment Reporting [Abstract]
Reportable segments | segment			2
Number of geographic regions in which entity operates | geographic_region	3		3
Segment Reporting Information [Line Items]
Ownership percentage (percent)	24.60%		24.60%
Net sales	$ 287,498	$ 255,843	$ 537,896	$ 482,668
Total reportable segment income from continuing operations	36,309	42,000	62,481	81,923
Merger and integration expenses	4,409	3,512	7,369	5,698
Charges	476	2,597	2,357	12,627
Amortization of intangibles	9,817	8,116	18,618	16,076
Operating income from continuing operations	21,607	27,775	34,137	47,522
Assets	2,597,136		2,597,136			$ 2,503,891
Capital expenditures	6,350	6,807	12,196	14,923
Operating Segments | Cardiac Surgery
Segment Reporting Information [Line Items]
Total reportable segment income from continuing operations			26,595	39,806
Charges	398	501	1,739	6,503
Operating Segments | Neuromodulation
Segment Reporting Information [Line Items]
Total reportable segment income from continuing operations			100,123	92,020
Charges	11	(233)	17	439
Other
Segment Reporting Information [Line Items]
Total reportable segment income from continuing operations	(41,417)	(33,037)	(64,237)	(49,903)
Charges	67	2,329	601	5,685
Assets	297,692		297,692			334,276
Capital expenditures	1,256	1,148	2,699	2,806
ImThera Medical, Inc.
Segment Reporting Information [Line Items]
Ownership percentage (percent)					86.00%
Continuing Operations | Operating Segments
Segment Reporting Information [Line Items]
Net sales	287,498	255,843	537,896	482,668
Continuing Operations | Operating Segments | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	176,456	158,586	332,628	297,790
Total reportable segment income from continuing operations	16,337	23,773
Assets	1,535,096		1,535,096			1,386,032
Capital expenditures	4,594	3,957	7,725	7,751
Continuing Operations | Operating Segments | Neuromodulation
Segment Reporting Information [Line Items]
Net sales	110,653	97,015	204,497	184,174
Total reportable segment income from continuing operations	61,389	51,264
Assets	764,348		764,348			532,894
Capital expenditures	500	517	847	1,978
Discontinued Operations
Segment Reporting Information [Line Items]
Assets	0		0			$ 250,689
Capital expenditures	0	1,185	925	2,388
United States | Continuing Operations | Operating Segments
Segment Reporting Information [Line Items]
Net sales	143,149	127,329	266,122	239,233
United States | Continuing Operations | Operating Segments | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	53,754	45,924	98,735	84,169
United States | Continuing Operations | Operating Segments | Neuromodulation
Segment Reporting Information [Line Items]
Net sales	89,395	81,405	167,387	155,064
Europe | Continuing Operations | Operating Segments
Segment Reporting Information [Line Items]
Net sales	60,075	54,157	119,352	103,042
Europe | Continuing Operations | Operating Segments | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	48,132	44,643	97,118	85,599
Europe | Continuing Operations | Operating Segments | Neuromodulation
Segment Reporting Information [Line Items]
Net sales	11,943	9,514	22,234	17,443
Rest of world | Continuing Operations | Operating Segments
Segment Reporting Information [Line Items]
Net sales	84,274	74,357	152,422	140,393
Rest of world | Continuing Operations | Operating Segments | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	74,570	68,019	136,775	128,022
Rest of world | Continuing Operations | Operating Segments | Neuromodulation
Segment Reporting Information [Line Items]
Net sales	9,315	6,096	14,876	11,667
Rest of world | Continuing Operations | Other
Segment Reporting Information [Line Items]
Net sales	389	242	771	704
UNITED KINGDOM
Segment Reporting Information [Line Items]
Net sales	8,400	9,200	16,600	17,300
Cardiopulmonary | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	136,639	124,145	261,769	231,443
Cardiopulmonary | United States | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	42,139	39,719	80,584	71,895
Cardiopulmonary | Europe | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	35,916	33,959	72,786	64,568
Cardiopulmonary | Rest of world | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	58,584	50,467	108,399	94,980
Heart Valves | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	33,802	34,441	64,844	66,347
Heart Valves | United States | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	6,147	6,205	12,683	12,274
Heart Valves | Europe | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	11,863	10,684	23,979	21,031
Heart Valves | Rest of world | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	15,792	17,552	28,182	33,042
Advanced Circulatory Support | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	6,015	0	6,015	0
Advanced Circulatory Support | United States | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	5,468	0	5,468	0
Advanced Circulatory Support | Europe | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	353	0	353	0
Advanced Circulatory Support | Rest of world | Cardiac Surgery
Segment Reporting Information [Line Items]
Net sales	$ 194	$ 0	$ 194	$ 0

X

- Definition

Income (Loss) from Reportable Segments before Income Taxes, Extraordinary Items, Noncontrolling Interest

+ References

No definition available.

+ Details

Name:	livn_IncomeLossfromReportableSegmentsbeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Namespace Prefix:	livn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Number of Geographic Regions in which Entity Operates

+ References

No definition available.

+ Details

Name:	livn_NumberofGeographicRegionsinwhichEntityOperates
Namespace Prefix:	livn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

X

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

+ Details

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name:	us-gaap_Assets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationIntegrationRelatedCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

+ References

No definition available.

+ Details

Name:	us-gaap_NumberOfReportableSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

No definition available.

+ Details

Name:	us-gaap_PropertyPlantAndEquipmentAdditions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747

+ Details

Name:	us-gaap_RestructuringCharges
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=livn_CardiacSurgeryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=livn_NeuromodulationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=livn_ImTheraMedicalInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentContinuingOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=srt_EuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=livn_RestOfWorldMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=country_GB
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=livn_CardiopulmonaryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=livn_HeartValvesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=livn_AdvancedCirculatorySupportMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: